Secondly, while we have identified and validated a potential mechanism involving WNT4, STAT3, and IGF2 in colon cancer using sequencing data and immunofluorescence techniques, additional technologies such as WB and PCR are required to verify their regulatory relationships.[37]. This evidence concerns the gene STAT3 and malignant colon neoplasm.